Fdc Sales Mis [2025]

Arjun realized the MIS had no field for retailer anxiety . No column for patient self-medication . No variable for regulatory trauma .

“Arjun bhai, your Nebuflam-D is moving slow because the retailers are scared. Two months ago, the state drug controller banned another FDC—same steroid, different company. The wholesalers are still stuck with thirty lakhs of expired stock. So now, every time a retailer sees ‘low-dose steroid’ on a combo, they think: next ban . They order just one strip at a time. And the patient? If the doctor writes a combo, the patient asks the chemist, ‘Can I take just the expectorant alone?’ Then they buy half a course.” Fdc Sales Mis

Arjun had been a regional sales manager for eleven years. He had seen doctors change prescription habits, drug reps morph into digital avatars, and CRM tools evolve from paper diaries to AI-driven dashboards. But nothing—nothing—had prepared him for the silence that came after the launch of the new FDC. Arjun realized the MIS had no field for retailer anxiety

And yet, week four of the launch, the MIS dashboard showed a flat green line where a hockey stick should have been. “Arjun bhai, your Nebuflam-D is moving slow because

He understood then what FDC sales MIS really was. Not a tool. Not a system. A mirror. And what it reflected was not the market, but the fear inside the people who sold drugs: fear of failure, fear of being fired, fear of a flat green line.

He walked out of the data entry room, past the janitor who had stopped humming, past the empty cubicles, past the motivational posters that said “Data is the new science.”